Loading...
•
Jun 30, 2023
LifeStance Q2 2023 Earnings Report
LifeStance's Q2 2023 financial performance reflected revenue growth driven by clinician growth and increased visit volumes, but was offset by increased expenses.
Key Takeaways
LifeStance Health Group reported a 24% increase in total revenue to $259.6 million for Q2 2023. The company's net loss was $45.5 million, driven by stock-based compensation expense. The company is raising full year revenue and Center Margin guidance, with the following outlook for 2023: expects full year revenue of $1.01 to $1.04 billion, Center Margin of $280 to $300 million, and Adjusted EBITDA of $50 to $62 million.
Total revenue increased 24% to $259.6 million.
Total clinicians reached 6,132, up 17% year-over-year.
Net loss was $45.5 million, compared to a net loss of $68.7 million in the prior year.
Adjusted EBITDA decreased 3% to $14.1 million.
Forward Guidance
LifeStance is raising full year revenue and Center Margin guidance, with the following outlook for 2023: expects full year revenue of $1.01 to $1.04 billion, Center Margin of $280 to $300 million, and Adjusted EBITDA of $50 to $62 million. For the third quarter of 2023, the Company expects total revenue of $250 to $260 million, Center Margin of $69 to $76 million, and Adjusted EBITDA of $11 to $17 million.
Positive Outlook
- Expecting full year 2023 revenue of $1.01 to $1.04 billion
- Expecting Center Margin of $280 to $300 million
- Reaffirming full year 2023 Adjusted EBITDA guidance of $50 to $62 million
- Expecting total revenue of $250 to $260 million for Q3 2023
- Expecting Center Margin of $69 to $76 million for Q3 2023
Challenges Ahead
- Expecting Adjusted EBITDA of $11 to $17 million for Q3 2023
- We may not grow at the rates we historically have achieved or at all
- If we fail to manage our growth effectively, our expenses could increase more than expected
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...